R&G PharmaStudies Co., Ltd. (SHE:301333)
China · Delayed Price · Currency is CNY 60.81
-1.49 (-2.39%)
At close: May 12, 2026
R&G PharmaStudies Employees
R&G PharmaStudies had 2,645 employees as of December 31, 2025. The number of employees increased by 437 or 19.79% compared to the previous year.
Employees
2,645
Change (1Y)
437
Growth (1Y)
19.79%
Revenue / Employee
338.85K CNY
Profits / Employee
50.53K CNY
Market Cap
5.98B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2,645 | 437 | 19.79% |
| Dec 31, 2024 | 2,208 | 166 | 8.13% |
| Dec 31, 2023 | 2,042 | 116 | 6.02% |
| Jan 1, 2023 | 1,926 | 1,298 | 206.69% |
| Dec 31, 2015 | 628 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Anhui Huaheng Biotechnology | 2,252 |
| Novogene | 2,190 |
| PharmaResources (Shanghai) | 1,085 |
| Wuhan Hvsen Biotechnology | 1,028 |
| Shenzhen Weiguang Biological Products | 859 |
| Beijing Konruns Pharmaceutical | 668 |
| Hangzhou Biotest Biotech | 622 |
| Jiangsu Bioperfectus Technologies | 586 |